Status:

COMPLETED

Efficacy of Diacerein Supplementation on Interleukin-1β, Hs-CRP, TNF-α Levels and Glycemic Control in Uncontrolled Type 2 Diabetes Mellitus Patients at Dr. Mohammad Hoesin General Hospital Palembang

Lead Sponsor:

Universitas Sriwijaya

Collaborating Sponsors:

Indonesia Endowment Fund for Education (LPDP), Ministry of Finance Republik of Indonesia

Conditions:

Uncontrolled Diabetes

Diabetes Mellitus Type 2

Eligibility:

All Genders

60-60 years

Phase:

PHASE2

PHASE3

Brief Summary

The goal of this clinical trial is to learn if diacerein supplementation can help improve inflammation and glycemic control in adults with uncontrolled type 2 diabetes. It will also study the safety a...

Detailed Description

The study aimed to evaluate the efficacy of diacerein supplementation compared to placebo towards interleukin-1β, hs-CRP, TNF-α levels and glycemic control in uncontrolled type 2 diabetes mellitus pat...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Patients diagnosed with uncontrolled type 2 diabetes mellitus who are receiving treatment at Dr. Mohammad Hoesin General Hospital, Palembang.
  • Male and female patients aged 40-59 years.
  • Willing to participate in the study by signing the informed consent form.
  • Exclusion Criteria
  • Pregnant or breastfeeding.
  • History of allergy to medications containing rhein.
  • Severe liver disorders.
  • Chronic kidney disease.
  • Malignancy.
  • Currently receiving hormone replacement therapy.
  • Autoimmune diseases.
  • Severe bacterial infection.
  • Osteoarthritis.
  • Use of other anti-inflammatory drugs within the past 2 weeks.
  • Drop-out Criteria
  • Patients who discontinue medication for more than 2 weeks.
  • Death.
  • Occurrence of serious adverse drug reactions requiring discontinuation of the medication.
  • Loss to follow-up.

Exclusion

    Key Trial Info

    Start Date :

    June 21 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 8 2024

    Estimated Enrollment :

    34 Patients enrolled

    Trial Details

    Trial ID

    NCT06912035

    Start Date

    June 21 2024

    End Date

    November 8 2024

    Last Update

    April 4 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Universitas Sriwijaya

    Palembang, South Sumatera, Indonesia, 30126